Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Knowledge and Intentions of French Adults Regarding Abusive Head Trauma in Infants: An Online Survey (VEAVE IV)

24 de julio de 2026 actualizado por: Assistance Publique - Hôpitaux de Paris

Knowledge and Behavioural Intentions of French Adults (18-80 Years) Regarding Abusive Head Trauma in Infants: Description and Associated Determinants From an Online Survey

Abusive head trauma (AHT) is a leading cause of infant mortality and long-term neurodevelopmental disability, yet existing prevention programmes have shown limited effectiveness in reducing its incidence. This may reflect insufficient understanding of upstream determinants of behaviour, including population-level knowledge of AHT.

This cross-sectional online study aims to assess AHT-related knowledge, behavioural intentions, and their determinants in a sample representative of the French adult population aged 18-80 years. Participants will be recruited through a quota-based online panel and social media.

Participants will complete a standardised procedure including exposure to short videos depicting either a shaking gesture (dangerous) or non-dangerous infant-handling behaviors (playing, rocking), followed by questionnaires assessing interpretation of the gesture, knowledge of its consequences, and AHT-related knowledge. After standardised information on AHT is provided, behavioral intentions and theoretical knowledge will be reassessed.

This study will provide the first nationally representative data on AHT-related knowledge in France and inform the development of targeted, evidence-based prevention strategies.

Descripción general del estudio

Estado

Aún no reclutando

Descripción detallada

Abusive Head Trauma (AHT) in infants is the most severe form of physical child abuse. It is defined as "an injury to the skull or intracranial contents of an infant or young child (under 5 years of age) resulting from inflicted blunt impact and/or violent shaking" (Parks, CDC). AHT is a leading cause of infant mortality, with mortality rates ranging from 7% to 26% (Niederkrotenthaler, Child Abuse Negl 2013; Hobbs, Arch Dis Child 2005; Ferguson, Crit Care Med 2017), and a major cause of long-term neurodevelopmental disability among survivors (Jayawant, Arch Dis Child 2007; Ferguson, Crit Care Med 2017). AHT predominantly affects infants younger than 2 years, with peak incidence between 2 and 4 months of age (Lee, J Dev Behav Pediatr 2007; Emrick, Child Abuse Negl 2019). Annual incidence has been estimated at 14 to 34 cases per 100,000 infants (Paget, Child Abuse Rev 2020; Rebbe, Child Abuse Rev 2020). Adult males are the most frequently identified perpetrators (Edwards, Child Abuse Rev 2020).

Over the past three decades, prevention programs have primarily focused on educating parents and caregivers about infant crying, the dangers of shaking, and strategies for stress regulation (Chang, Trauma Violence Abuse 2024; Scott, Child Abuse Negl 2022; Prokofevia, Child Abuse Negl 2026). However, several meta-analyses have reported no significant reduction in AHT incidence following such interventions (Viswanathan, JAMA 2024). These findings underscore the need to better understand upstream determinants of behavior, including knowledge, which is a key construct in many behavior change theories (Ajzen, 2005).

International studies (eg, Germany (Berthold, Pediatr Res 2019), Saudi Arabia (AlOmran, Pan Afr Med J 2022), China (Gao, Child Abuse Negl 2021), Ireland (Mann, Eur J Pediatr 2015)) report that 41% to 69% of respondents had never heard of AHT. However, these studies have several limitations. Most are single-center, involve small sample sizes, and exhibit heterogeneous methodological quality. Recruitment has typically been restricted to parents, excluding other adults who regularly care for or interact with infants. In addition, most studies assess knowledge of AHT and its consequences without providing a clear definition of AHT or explicitly evaluating recognition of the shaking behavior that can lead to AHT. Only one study has used video-based stimuli to assess recognition of shaking; however, it relied on a neutral prompt without confirmation of the nature of the depicted action, thereby limiting the validity of the knowledge assessment. Observed levels of knowledge vary widely across studies, likely reflecting both true population heterogeneity and methodological inconsistency. Data on determinants of AHT-related knowledge remain scarce. In France, in particular, no nationally representative data are available; existing studies are limited to small, single-center samples recruited in maternity settings.

This cross-sectional online survey aims to assess AHT-related knowledge, behavioral intentions, and determinants of knowledge in a sample representative of the French adult population.

Recruitment will be conducted by IPSOS BVA (organization specialized in survey and panel research) using two channels: (1) a quota-based online panel, representative of the French adult population, and (2) social media. This approach will yield three independent samples of adults aged 18-80 years residing in France. Sample 1 (n = 1,000; general population, representative) will be recruited via the online panel and supplemented with a targeted oversample of 200 men aged 18-40 years, the demographic group most frequently identified as perpetrators of AHT, recruited through social media. Sample 2 (n = 1,000; general population, representative) and Sample 3 (n = 1,000; general population, representative) will both be recruited via the online panel.

All participants will complete the same sequential procedure. First, participants will complete an 8-item sociodemographic questionnaire. Each sample will then be exposed to one short video stimulus (6-8 seconds; motion design): Sample 1 will view Video 1 (depicting a shaking gesture, representing a situation that may cause AHT); Sample 2 will view Video 2 (depicting a knee-bouncing gesture, representing a non-dangerous play activity); and Sample 3 will view Video 3 (depicting a rocking gesture, representing a non-dangerous soothing activity). After viewing their assigned video, participants will complete a 5-item questionnaire assessing their perception of the depicted gesture, their knowledge about the potential consequences of the gesture, and their knowledge about AHT. Subsequently, all participants will then view Video 1 (shaking gesture), accompanied by explicit information indicating that the depicted behaviour may cause AHT, along with a standardised operational definition of AHT. Participants will then complete a 4-item questionnaire assessing behavioral intentions and theoretical knowledge related to AHT.

AHT-related knowledge will be assessed by combining questionnaire responses into predefined categories: "perfect responder", graded levels of "intermediate responders", "incorrect responder", and "incoherent responder". Classification rules will be established a priori by a panel of experts in AHT. Descriptive analyses will be conducted to characterise the study population and to describe levels of AHT-related knowledge and behavioral intentions. Associations between participant characteristics (potential determinants) and AHT-related knowledge will be examined using appropriate statistical methods.

This study will provide the first nationally representative data on AHT-related knowledge among adults in France and will inform the development of targeted, evidence-based AHT prevention strategies.

Tipo de estudio

De observación

Inscripción (Estimado)

3200

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Enora Le ROUX, PhD
  • Número de teléfono: + 33 1 40 03 23 66
  • Correo electrónico: enora.leroux@aphp.fr

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

Participants will be recruited through a collaboration with IPSOS BVA, a survey research organization, using a pre-existing online panel designed to be representative of the French adult general population (based on quotas), as well as social media for supplementation in one subsample. Panel members have previously provided informed consent to participate in surveys on a broad range of topics, including health-related subjects. We will recruit 3000 adults aged 18-60 years, representative of the French population, as well as 200 male adults aged 18-40 to supplement the overall sample with a population more at risk of being potential perpatrators as reported in the scientific literature.

Descripción

Inclusion Criteria:

  • Adults (any gender) between 18-80 years
  • Living in France
  • Fluent in French

Exclusion Criteria:

  • Non-French speakers, as the questionnaire is only available in French
  • Refusal to participate in the research

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Group 1
1200 participants (1000 recruited through an online panel, oversample of 200 male adults aged 18-40 years recruited through social media) first exposed to Video 1 (depicting a shaking gesture in motion design, potentially causing AHT).
Group 2
1000 participants (recruited through an online panel) first exposed to Video 2 (depicting a bouncing on knees gesture in motion design, not a dangerous playing situation).
Group 3
1000 participants (recruited through an online panel) first exposed to Video 3 (depicting a rocking gesture in motion design, not a dangerous situation).

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Proportion of correct answers
Periodo de tiempo: At baseline

Proportion of participants providing correct answers to AHT-related knowledge questions (AHT-related knowledge).

AHT-related knowledge will be assessed using a categorical variable classifying participants as "perfect," "intermediate" (with sub-levels), "incorrect," or "incoherent" responders, based on their answers to knowledge questions administered after viewing the assigned video (video 1, 2, or 3) and prior to disclosure of the definition of AHT. The response combinations used to construct this categorical variable will be determined by consensus among a panel of AHT experts.

At baseline

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Proportion of risk gesture
Periodo de tiempo: at baseline

Proportion of participants reporting ever having experienced an urge to perform a gesture at risk of causing AHT and the coping strategies employed to resist acting on such urges (AHT-related intentions).

AHT-related intentions and coping strategies will be assessed through two questions administered after disclosure of the definition of AHT: (1) a question assessing whether the participant has ever experienced an urge to perform a gesture at risk of causing AHT (eg, shaking an infant); and (2) among those responding affirmatively, an open-ended or multiple-choice question assessing the coping strategies employed to resist acting on such urges.

at baseline
Determinants, among sociodemographic variables, of AHT-related knowledge in the French adult population
Periodo de tiempo: at baselin
The following sociodemographic variables will be collected and explored as potential determinants of AHT-related knowledge: age (continuous), sex (categorical), parity (categorical), educational level (categorical), socioeconomic position (categorical), and subjective experience of poverty (categorical). Associations between these variables and AHT-related knowledge will be examined using appropriate statistical methods for categorical and continuous determinants.
at baselin

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Colaboradores

Investigadores

  • Investigador principal: Enora Le ROUX, PhD, Paris-Saclay West Clinical Research Unit, Sainte-Pérrine Hospital, APHP
  • Director de estudio: Martin CHALUMEAU, MD, PhD, Department of General Pediatrics and Infectious Diseases, Necker Hospital, APHP

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

30 de septiembre de 2026

Finalización del estudio (Estimado)

31 de octubre de 2026

Fechas de registro del estudio

Enviado por primera vez

24 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

24 de julio de 2026

Publicado por primera vez (Actual)

30 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

30 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

24 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • APHP260554

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir